Edward Nirenberg on Nostr: With the decline of meningococcal in 11-12-year-olds, the vaccine at this age becomes ...
With the decline of meningococcal in 11-12-year-olds, the vaccine at this age becomes less important BUT it very well could be that the decline is because of vaccination in this age group. The cost effectiveness of this vaccine is very difficult because of the rarity of disease.
Published at
2024-06-28 14:15:57Event JSON
{
"id": "f8be6e525fc5970571cf0e8ce3442c7b4bfdf15c2dce20a01352532d27680477",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1719584157,
"kind": 1,
"tags": [
[
"e",
"477dcacf57be388a3bd575a50b23c6dd99d5b225af0df250942be9529d9acafc",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/112694667323628865",
"activitypub"
]
],
"content": "With the decline of meningococcal in 11-12-year-olds, the vaccine at this age becomes less important BUT it very well could be that the decline is because of vaccination in this age group. The cost effectiveness of this vaccine is very difficult because of the rarity of disease.",
"sig": "ecfdfd1ae16081a8de9e10f72a33f3e0a6d905725235d7814613617d6ecc0d690ef700f948b5c65cf93fa5d02f538058b7a5cfaf3baf902e778975c0060025d5"
}
